We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1051
First Commonwealth Financial
FCF
$2.04B
| $1.31M | ﹤0.01% |
80,596
-43,157
| -35% | -$666K |
2015 Q4
38 quarters
|
|
1052
Amylyx Pharmaceuticals
AMLX
$3.47B
| $1.31M | ﹤0.01% |
203,930
+1,145
| +0.6% | +$5.57K |
2022 Q3
11 quarters
|
|
1053
Dole
DOLE
$1.27B
| $1.31M | ﹤0.01% |
93,339
-259
| -0.3% | -$3.67K |
2024 Q3
3 quarters
|
|
1054
Johnson Controls International
JCI
$89.4B
| $1.31M | ﹤0.01% |
12,359
+6,760
| +121% | +$622K |
2013 Q2
48 quarters
|
|
1055
Honeywell
HON
$66.7B
| $1.3M | ﹤0.01% |
5,944
-297
| -5% | -$60.1K |
2013 Q2
48 quarters
|
|
1056
Watsco Inc
WSO
$12.4B
| $1.3M | ﹤0.01% |
2,944
-93
| -3% | -$43.1K |
2013 Q2
48 quarters
|
|
1057
Horizon Bancorp
HBNC
$992M
| $1.3M | ﹤0.01% |
84,461
+22,935
| +37% | +$337K |
2013 Q2
48 quarters
|
|
1058
MasTec
MTZ
$15.4B
| $1.3M | ﹤0.01% |
7,600
-1,092
| -13% | -$157K |
2015 Q4
38 quarters
|
|
1059
Coherent
COHR
$49.4B
| $1.29M | ﹤0.01% |
14,511
-163
| -1% | -$11.7K |
2019 Q3
23 quarters
|
|
1060
Tiptree Inc
TIPT
$619M
| $1.29M | ﹤0.01% |
54,896
+74
| +0.1% | +$1.65K |
2023 Q1
9 quarters
|
|
1061
Park Hotels & Resorts
PK
$3.17B
| $1.28M | ﹤0.01% |
125,268
-7,074
| -5% | -$72K |
2019 Q3
23 quarters
|
|
1062
AGNC Investment
AGNC
$10.5B
| $1.28M | ﹤0.01% |
139,356
+3,611
| +3% | +$32.3K |
2022 Q4
10 quarters
|
|
1063
Performance Food Group
PFGC
$15.3B
| $1.27M | ﹤0.01% |
14,571
-221
| -1% | -$18.4K |
2021 Q3
15 quarters
|
|
1064
Tapestry
TPR
$23.8B
| $1.27M | ﹤0.01% |
14,514
-15,822
| -52% | -$1.2M |
2013 Q2
48 quarters
|
|
1065
Mativ Holdings
MATV
$644M
| $1.27M | ﹤0.01% |
186,304
+185,593
| +26,103% | +$1.07M |
2024 Q4
2 quarters
|
|
1066
Hain Celestial
HAIN
$25.7M
| $1.27M | ﹤0.01% |
834,586
-224,716
| -21% | -$525K |
2013 Q2
48 quarters
|
|
1067
Universal Insurance Holdings
UVE
$1.3B
| $1.27M | ﹤0.01% |
45,673
-29
| -0.1% | -$736 |
2023 Q4
6 quarters
|
|
1068
IonQ
IONQ
$13.9B
| $1.26M | ﹤0.01% |
+29,364
| New | +$984K |
2025 Q2
0 quarters
|
|
1069
Gibraltar Industries
ROCK
$1.17B
| $1.26M | ﹤0.01% |
21,347
-942
| -4% | -$53.9K |
2022 Q1
13 quarters
|
|
1070
SiriusXM
SIRI
$9.15B
| $1.24M | ﹤0.01% |
54,122
+1,059
| +2% | +$22.8K |
2024 Q4
2 quarters
|
|
1071
Burlington
BURL
$16.8B
| $1.23M | ﹤0.01% |
5,305
-16,762
| -76% | -$3.98M |
2023 Q4
6 quarters
|
|
1072
H2O America
HTO
$2.4B
| $1.23M | ﹤0.01% |
23,662
+23,482
| +13,046% | +$1.25M |
2025 Q1
1 quarter
|
|
1073
Rithm Capital
RITM
$4.86B
| $1.23M | ﹤0.01% |
108,638
-44,813
| -29% | -$494K |
2025 Q1
1 quarter
|
|
1074
Lands' End
LE
$304M
| $1.23M | ﹤0.01% |
114,398
+47,955
| +72% | +$434K |
2024 Q2
4 quarters
|
|
1075
NETSTREIT Corp
NTST
$1.76B
| $1.22M | ﹤0.01% |
+72,278
| New | +$1.16M |
2025 Q2
0 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.